Product Information

SEVELAMER CARBONATE 800 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.2089 per EA under NDC 69097096793. Its NADAC has been published 364 times since Dec 4, 2019.

FDA first approved this application on Oct 26, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SEVELAMER CARBONATE 800 MG TAB

SEVELAMER CARBONATE
$0.2089per EA

Strength

800 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097096793

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

SEVELAMER CARBONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA203860

FDA Approved

10/26/2017

TE Code

AB

On Market Since

10/26/2017

Pharmacological Classes

Phosphate Binder
Phosphate Chelating Activity

Price Statistics

The NADAC for SEVELAMER CARBONATE 800 MG TAB has been published 364 times since Dec 4, 2019, and over the history we have for it it has declined 48.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2089 per EA
All-time high$0.4269 (Feb 12, 2020)
All-time low$0.1833 (Nov 20, 2024)
52-week high$0.2285
52-week low$0.2074
Median price$0.2422
Average price$0.2639
Largest weekly change-26.6% (Jan 20, 2021)
Weeks tracked364
Tracking sinceDec 4, 2019

Price History

1W

-2.2%

1M

-2.4%

3M

-4.5%

6M

-8.1%

1Y

-5.1%

3Y

-14.4%

5Y

-33.3%

All

-48.5%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SEVELAMER CARBONATE 800 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER CARBONATE 800 MG TAB, manufactured by Cipla USA Inc., is $0.2089 per EA (NDC 69097096793), effective Nov 18, 2026.

How has the price of SEVELAMER CARBONATE 800 MG TAB changed over time?

Over the history we have for it, the NADAC for SEVELAMER CARBONATE 800 MG TAB has declined 48.5%. It has been tracked across 364 weekly CMS publications since Dec 4, 2019.

What are the highest and lowest recorded NADAC prices for SEVELAMER CARBONATE 800 MG TAB?

Since Dec 4, 2019, the NADAC for SEVELAMER CARBONATE 800 MG TAB has ranged from a low of $0.1833 (Nov 20, 2024) to a high of $0.4269 (Feb 12, 2020), with a median of $0.2422 per EA.

Are there cheaper alternatives to SEVELAMER CARBONATE 800 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SEVELAMER CARBONATE 800 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures SEVELAMER CARBONATE 800 MG TAB?

SEVELAMER CARBONATE 800 MG TAB (NDC 69097096793) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.